VBI Vaccines down 12% ahead of corporate presentation
VBI Vaccines (VBIV-12.4%) is down on more than a 5x surge in volume ahead of a corporate presentation today at the BMO Capital Markets Healthcare Conference by President & CEO Jeff Baxter. He is scheduled to take the podium at 11:20 am ET.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.